Labshake search
Citations for Cayman Chemical :
1 - 24 of 24 citations for VIP Antagonist since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2020Quote: ... EP2 antagonist AH6809 (Cayman Chemicals), EP4 antagonist GW627368X (Cayman Chemicals ...
-
bioRxiv - Immunology 2020Quote: ... EP4 antagonist GW627368X (Cayman Chemicals) or AH23848 (Cayman Chemicals) ...
-
bioRxiv - Immunology 2021Quote: ... EP2 receptor antagonist AH6809 (Cayman Chemical) at 5 μM or EP4 receptor antagonist AH23848 (Cayman Chemical ...
-
bioRxiv - Pathology 2020Quote: ... SCH79797 (PAR-1 antagonist) and GB-83 (PAR-2 antagonist) were purchased from Cayman Chemicals (Michigan, USA). U0126 (MEK 1/2 inhibitor) ...
-
bioRxiv - Immunology 2023Quote: ... or receptor antagonist U7530252 (10μM, Cayman Chemical) where 4e5 neutrophils (in RPMI with 10% HI70 FBS ...
-
bioRxiv - Neuroscience 2023Quote: ... and TRPV1 antagonist Capsazepine (5mg/kg; Cayman Chemicals) were prepared on the day of injection in vehicle solution (5% polyethylene glycol ...
-
bioRxiv - Cell Biology 2023Quote: ... All the antagonists were purchased from Cayman Chemical.
-
bioRxiv - Immunology 2021Quote: The EP2 antagonist PF-04418948 (catalog # 15016) and the EP4 antagonist ONO-AE3-208 (catalog # 14522) were purchased from Cayman Chemical. Mice were given daily doses of 10mg/kg EP2 and/or 10mg/kg EP4 antagonist(s ...
-
bioRxiv - Immunology 2021Quote: ... the IL-1R antagonist (20 μM, Cayman Chemical Company), IKK-16 (20 μM ...
-
bioRxiv - Immunology 2021Quote: ... the TGF-β1 receptor ALK5 antagonist SB431542 (Cayman Chemical), or the SMAD3 phosphorylation inhibitor SIS3 (Cayman Chemical ...
-
bioRxiv - Cell Biology 2020Quote: ... PPARα antagonist (GW6471) was purchased from Cayman chemical (11697). PPARγ antagonist was purchased from Sigma (M6191) ...
-
bioRxiv - Physiology 2023Quote: ... a selective S1PR1 antagonist (Cayman Chemical; Catalogue number: 10009109), was freshly prepared under sterile conditions on the same day of experiments ...
-
bioRxiv - Immunology 2021Quote: ... at 5 μM or EP4 receptor antagonist AH23848 (Cayman Chemical) at 10 μM ...
-
bioRxiv - Neuroscience 2023Quote: ... and antagonist SB 277011A (SB; Cayman Chemical, Ann Arbor, MI) were dissolved in 2.5% DMSO ...
-
bioRxiv - Cancer Biology 2022Quote: ... For LPAR1/3 inhibitor treatment with KI16425 antagonist (Cayman chemicals, #10012659), cells were incubated for 1h in serum free medium in 1:1000 dilution prior preparation and assembly of the “Insall” chambers ...
-
bioRxiv - Immunology 2021Quote: Neutrophils were pre-treated with the CXCR2 receptor antagonist AZD5069 (Cayman Chemical), the TGF-β1 receptor ALK5 antagonist SB431542 (Cayman Chemical) ...
-
bioRxiv - Cell Biology 2019Quote: ... antagonist of PPAR-γ was purchased from Cayman Chemicals (St Louis, MO, U.S.A.)
-
bioRxiv - Neuroscience 2021Quote: ... we incubated cells with the antagonist HC03003121 (40μM in DMSO; Cayman Chemicals #11923) for 45 min before stimulation ...
-
bioRxiv - Neuroscience 2022Quote: ... and the neutral CB1 receptor antagonist NESS0327 (0.3mg/kg; Cayman Chemical, Ann Arbor, MI, USA) were administered 15 minutes prior to behavioral recording ...
-
bioRxiv - Neuroscience 2022Quote: ... The CB1 receptor antagonist/inverse agonist AM251 (3mg/kg; Cayman Chemical, Ann Arbor, MI, USA) and the neutral CB1 receptor antagonist NESS0327 (0.3mg/kg ...
-
bioRxiv - Physiology 2023Quote: ... An EP4 antagonists (CJ42794, ONO-AE3-208) were purchased from Cayman Chemicals (Ann Arbor, MI, USA). Prostaglandin E2 (PGE2 ...
-
bioRxiv - Developmental Biology 2020Quote: A selective ESR2 antagonist PHTPP (46) or a selective ESR2 agonist DPN (47) (Cayman Chemical, Ann Arbor, MI) was dissolved in DMSO (5µg/µl) ...
-
bioRxiv - Immunology 2022Quote: Mice were pre-treated via intraperitoneal (ip) injections with either S1P receptor antagonist FTY720 (1 mg/kg, Cayman Chemical), anti-CXCR3 antibody (250 μg/mouse ...
-
bioRxiv - Neuroscience 2020Quote: ... or with a mixture of 25 mM KCl and 5 μM NMDA receptor antagonist D-2-amino-5-phosphopentanoic acid (D-APV, Cayman Chemical Company) to study BDNF autoregulation or neuronal activity-dependent expression of the BDNF gene ...